EtOH and Drug induced liver diseases Flashcards
Pathogenesis of EtOH liver disease
Chronic EtOH misuse –> inflammation, apoptosis, fibrosis and reduced regeneration of hepatocytes
90-95% –> steatosis
10-20% –> fibrosis
8-20% –> cirrhosis
3-10% –> HCC
Risk factors for EtOH liver disease
Female Binge drinking Viral hepatitis HIV Obesity Smoking
Genetics - PNPLA3
Histological changes of EtOH
Mallory hyaline = EtOH
Hepatitis = neutrophils, fatty changes, necrosis of hepatocytes
Management of acute EtOH hepatitis
Low risk
= MDF <32or MELD<18
= Nutritional intervention
High risk = MDF >32 or MELD >18 = Nutritional intervention = Prednisone = NAC
Acute changes to ALT in drug induced hepatitis
ALT raised +++ Then quickly falls with removal of drug
Bilirubin peaks high and later then falls to normal
Paracetamol metabolism
90% metabolised into inactive sulphate and glucuronide conjugates that are excreted in the urine
10% = cytochrome P450 –> formation of NAPQI
NAPQI –> bound to intracellular glutathione –> elimination in urine as mercapturic adducts
Treatment of paracetamol OD
NAC infusion until paracetamol levels normalise or INR and ALT/AST are normal
Criteria of liver transplant in paracetamol OD
pH <7.3
OR
INR >6.5 and creatinine >340 and encephalopathy
Common causes of drug induced cholestasis
Chlorpromazine Anti-androgens OCP Ketoconazole Flucloxacillin Amoxy/clav Diclox NSAIDS Psychotropics